Evidence map›Paper›PMID 21437029›Full record

ArticleGenes & nutrition2011

Human iron transporters.

Michael D Garrick

Abstract read
In one paragraph

Article in Genes & nutrition, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Of mitochondrion and COVID-19.Journal of enzyme inhibition and medicinal chemistry · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Changes of ferrous iron and its transporters after intracerebral hemorrhage in rats.International journal of clinical and experimental pathology · 2015
    Article
  14. Article
  15. Review
  16. Paradoxical effects of heme arginate on survival of myocutaneous flaps.American journal of physiology. Regulatory, integrative and comparative physiology · 2014
    Article
  17. Article
  18. Article
  19. Manganese in health and disease.Metal ions in life sciences · 2013
    Review
  20. Pharmacology of iron transport.Annual review of pharmacology and toxicology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Michael D GarrickDepartment of Biochemistry, 140 Farber Hall, SUNY at Buffalo, 3435 Main St., Buffalo, NY 14214 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human iron transporters manage iron carefully because tissues need iron for critical functions, but too much iron increases the risk of reactive oxygen species. Iron acquisition occurs in the duodenum via divalent metal transporter (DMT1) and ferroportin. Iron trafficking depends largely on the transferrin cycle. Nevertheless, non-digestive tissues have a variety of other iron transporters that may render DMT1 modestly redundant, and DMT1 levels exceed those needed for the just-mentioned tasks. This review begins to consider why and also describes advances after 2008 that begin to address this challenge.

Indexed as

Divalent metal transporter (DMT1)Ferric reductaseFerroportinIron regulatory protein (IRP)Iron-responsive element (IRE)IsoformsTransferrin

Identifiers

PMID21437029
PMCPMC3040799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.